Compare LAKE & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | ANIK |
|---|---|---|
| Founded | 1982 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 142.5M |
| IPO Year | 1986 | 1993 |
| Metric | LAKE | ANIK |
|---|---|---|
| Price | $15.39 | $9.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $25.00 | $16.00 |
| AVG Volume (30 Days) | 97.6K | ★ 178.2K |
| Earning Date | 12-09-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $191,631,000.00 | $112,806,000.00 |
| Revenue This Year | $29.73 | N/A |
| Revenue Next Year | $8.45 | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 39.13 | 30.55 |
| 52 Week Low | $12.76 | $7.87 |
| 52 Week High | $27.28 | $18.37 |
| Indicator | LAKE | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 48.00 |
| Support Level | $14.55 | $9.76 |
| Resistance Level | $15.85 | $10.17 |
| Average True Range (ATR) | 0.62 | 0.36 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 77.78 | 40.00 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.